Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer

NCT06513962 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT06513962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06513962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Recruiting
Start date
February 27, 2025
Completion date
October 30, 2029
Enrollment
60 (estimated)
Sites
206

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphatic system neoplasm, malignant solid neoplasm